研究单位:[1]BeiGene[2]St. Joseph Heritage Healthcare,Fullerton,California,United States,92835[3]University of Southern California Norris Comprehensive Cancer Center,Los Angeles,California,United States,90089-0112[4]Northwestern Medicine Cancer Center Warrenville,Warrenville,Illinois,United States,60555[5]Henry Ford Hospital,Detroit,Michigan,United States,48202[6]Toledo Clinic Cancer Center,Toledo,Ohio,United States,43623[7]San Antonio Military Medical Center,Fort Sam Houston,Texas,United States,78234[8]Millennium Oncology,Houston,Texas,United States,77090[9]Imelda Ziekenhuis,Antwerp,Belgium,2600[10]UZ Antwerpen,Antwerp,Belgium,2650[11]Cliniques universitaires Saint-Luc,Brussels,Belgium,1000[12]University Hospitals Leuven,Leuven,Belgium,3000[13]Centre Hospitalier Universitaire (CHU) de Liege - Site du Sart Tilman,Liege,Belgium,4000[14]Anhui Medical University - The Second Hospital,Hefei,Anhui,China,230601[15]Beijing Friendship Hospital,Beijing,Beijing,China,100050[16]Beijing Cancer Hospital,Beijing,Beijing,China,100142[17]Peking Union Medical College Hospital,Beijing,Beijing,China,100730[18]Fujian Medical University Union Hospital,Fuzhou,Fujian,China,350001[19]The First Affiliated Hospital of Fujian Medical University,Fuzhou,Fujian,China,350005[20]Fujian Provincial Cancer Hospital,Fuzhou,Fujian,China,350014[21]The First Affiliated Hospital of Xiamen University,Xiamen,Fujian,China,361004[22]The First Hospital, Sun Yat-sen University,Guangzhou,Guangdong,China,510080[23]The Sixth Affiliated Hospital of Sun Yat-sen University,Guangzhou,Guangdong,China,510655[24]Cancer Hospital of Shantou University Medical College,Shantou,Guangdong,China,515031[25]Peking University Shenzhen Hospital,Shenzhen,Guangdong,China,518035[26]Affiliated Hospital of Hebei University,Baoding,Hebei,China,71000[27]Fourth Hospital of Hebei Medical University,Shijiazhuang,Hebei,China,050011[28]Harbin Medical University Cancer Hospital,Harbin,Heilongjiang,China,150081[29]The First Affiliated Hospital of Xinxiang Medical University,Xinxiang,Henan,China,453100[30]Henan Cancer Hospital,Zhengzhou,Henan,China,450008[31]The First Affiliated Hospital of Zhengzhou University,Zhengzhou,Henan,China,450052[32]Hubei Cancer Hospital,Wuhan,Hubei,China,400037[33]Xiangyang Central Hospital,Xiangyang,Hubei,China,441000[34]Hunan Cancer Hospital,Changsha,Hunan,China,410013[35]The First People's Hospital Of Changzhou,Changzhou,Jiangsu,China,213003[36]Huai'an Second People's Hospital,Huai'an,Jiangsu,China,223002[37]Jiangsu Province Hospital,Nanjing,Jiangsu,China,210029[38]Nanjing Drum Tower Hospital,Nanjing,Jiangsu,China,21008[39]Nantong Tumor Hospital,Nantong,Jiangsu,China,226000[40]The Affiliated Hospital of Xuzhou Medical University,Xuzhou,Jiangsu,China,221002[41]Jiangxi Cancer Hospital,Nanchang,Jiangxi,China,330029[42]The First Hospital of Jinlin University,Changchun,Jilin,China,130021[43]Shandong Cancer Hospital,Jinan,Shandong,China,250117[44]Shandong Linyi Tumor Hospital,Linyi,Shandong,China,371300[45]WeiFang People's Hospital,Weifang,Shandong,China,261000[46]Fudan Cancer Hospital,Shanghai,Shanghai,China,200032[47]Shanxi Provincial People's Hospital,Taiyuan,Shanxi,China,140100[48]The Second Affiliated Hospital of Xi'an Jiaotong University(Xibei Hospital),Xi'an,Shanxi,China,710014[49]Sichuan Academy of Medical Sciences& Sichuan Provincial People's Hospital,Chengdu,Sichuan,China,610071[50]Yunnan Cancer Hospital - Oncology,Kunming,Yunnan,China,650100[51]Hangzhou First People's Hospital,Hangzhou,Zhejiang,China,310006[52]The First Affiliated Hospital, Zhejiang University,Hangzhou,Zhejiang,China,310006[53]Zhejiang Cancer Hospital,Hangzhou,Zhejiang,China,310022[54]CHRU Besançon,Besançon,France,25000[55]CHRU de Brest Hôpital Morvan,Brest,France,29200[56]Centre Georges-Francois Leclerc,Dijon,France,21079[57]Center Oscar Lambret - Alliance Member,Lille,France,59000[58]Hopital Prive Jean Mermoz,Lyon,France,69008
The purpose of this study was to evaluate the efficacy and safety of tislelizumab as second line treatment in participants with advanced unresectable/metastatic ESCC that had progressed during or after first line therapy.